Clinical decision-making insights for haem/oncsDespite the effects of countries’ lockdown policies, a plethora of clinical trial readouts continue to emerge providing several Share XClinical decision-making insights for haem/oncshttps://pharmaphorum.com/oncology/clinical-decision-making-insights-haem-oncs/
How to win with a multichannel approach in pharmaA multichannel marketing approach, together with compelling content, is the ultimate way for pharma to deliver the message Share XHow to win with a multichannel approach in pharmahttps://pharmaphorum.com/digital/multichannel-approach-pharma-viseven/
Accelerating pharma’s digital IQ as customer engagement evolvesThe COVID-19 pandemic has brought many changes to the pharmaceutical industry, among them how companies can continue to Share XAccelerating pharma’s digital IQ as customer engagement evolveshttps://pharmaphorum.com/digital/veeva-customer-engagement-webinar/
Unlocking health data to improve oncology outcomesThe NHS’ globally unique health data ecosystem has the potential to improve health outcomes. With around 363,000 new Share XUnlocking health data to improve oncology outcomeshttps://pharmaphorum.com/oncology/unlocking-health-data-to-improve-oncology-outcomes/
The new global digital health paradigm in life sciencesDigital transformation has long been a priority for all life science companies and it has been made even Share XThe new global digital health paradigm in life scienceshttps://pharmaphorum.com/r-d/10-years-in-10-days-the-new-global-digital-health-paradigm-in-life-sciences/
COVID-19 briefing: coronavirus impacts for UK and Ireland pharma and biotechOverview This April webinar is part of IQVIA’s monthly updates on the impact of COVID-19 and its implications Share XCOVID-19 briefing: coronavirus impacts for UK and Ireland pharma and biotechhttps://pharmaphorum.com/r-d/iqvia-covid-19-april-briefing-impact-for-pharma-and-biotech/
The COVID-19 coronavirus and pharma and biotech continuity planningOverview Pharmaceutical and biotech companies around the globe are working with Governments to address the COVID-19 outbreak, from Share XThe COVID-19 coronavirus and pharma and biotech continuity planninghttps://pharmaphorum.com/r-d/the-potential-impact-of-coronavirus-covid-19-for-global-pharma-and-biotech-continuity/
How ‘thinking modular’ might ease digital content overload in pharmaOverview In today’s digital world it is increasingly hard for pharmaceutical companies to successfully differentiate new brands based Share XHow ‘thinking modular’ might ease digital content overload in pharmahttps://pharmaphorum.com/sales-marketing/how-thinking-modular-might-ease-digital-content-overload-in-pharma/
Applying behavioural interventions in chronic diseasesOverview Chronic diseases are the leading cause of death and disability worldwide and have a staggering impact on Share XApplying behavioural interventions in chronic diseaseshttps://pharmaphorum.com/sales-marketing/applying-behavioural-interventions-in-chronic-diseases/
